Parathyroid resistance to FGF23 in kidney transplant recipients: back to the past or ahead to the future?
- PMID: 21030971
- DOI: 10.1038/ki.2010.283
Parathyroid resistance to FGF23 in kidney transplant recipients: back to the past or ahead to the future?
Abstract
Fibroblast growth factor 23 (FGF23) modulates the metabolism of minerals and vitamin D. In chronic kidney disease (CKD), this process is disturbed owing to decreased parathyroid expression of FGF23's receptor complex Klotho-FGF receptor 1. In this issue, Krajisnik and colleagues demonstrate that similar alterations occur in parathyroid glands from kidney transplant recipients in association with a decline in allograft function. Is it possible that these data can be extrapolated to general early-stage CKD patients?
Comment on
-
Parathyroid Klotho and FGF-receptor 1 expression decline with renal function in hyperparathyroid patients with chronic kidney disease and kidney transplant recipients.Kidney Int. 2010 Nov;78(10):1024-32. doi: 10.1038/ki.2010.260. Epub 2010 Aug 4. Kidney Int. 2010. PMID: 20686451
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
